Clinical Trials Logo

Multiple Sclerosis, Relapse Free clinical trials

View clinical trials related to Multiple Sclerosis, Relapse Free.

Filter by:
  • None
  • Page 1

NCT ID: NCT01433497 Completed - Clinical trials for Multiple Sclerosis, Secondary Progressive

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of masitinib 6 mg/kg/day versus placebo in the treatment of patients with primary progressive multiple sclerosis or relapse-free secondary progressive multiple sclerosis.